{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.4:c.136G>A",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "A",
            "position": "136"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "46"
          },
          "Description in input context": "E46K mutation in the αS gene"
        },
        {
          "HGVS": "NM_000345.4:c.88G>C",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "C",
            "position": "88"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P mutation in the αS gene"
        },
        {
          "HGVS": "NM_000345.4:c.157G>A",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "A",
            "position": "157"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T mutation in the αS gene"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Lewy body diseases (LBD)",
    "MONDO": "MONDO:0005180"
  },
  "Experiment Method": [
    {
      "Assay Method": "Thioflavin S assay",
      "Material used": {
        "Material Source": "Recombinant peptides",
        "Material Name": "WT, E46K, A30P, A53T, A30P/A53T αS",
        "Description": "Wild-type αS (WT) and mutant αS peptides (E46K, A30P, A53T, A30P/A53T) were purchased from Recombinant Peptide Technologies."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.136G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "accelerated fibril formation",
          "Result Description": "E46K αS accelerated the kinetics of the secondary structure change and oligomerization."
        },
        {
          "Variant": "NM_000345.4:c.88G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "decelerated fibril formation",
          "Result Description": "A30P αS decelerated the kinetics of the secondary structure change and oligomerization."
        },
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "accelerated fibril formation",
          "Result Description": "A53T αS accelerated the kinetics of the secondary structure change and oligomerization."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Each figure comprises data obtained with 3 independent experiments."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Fluorescence was determined three times at intervals of 10 s."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type αS was used as a control."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Circular dichroism spectroscopy",
      "Material used": {
        "Material Source": "Recombinant peptides",
        "Material Name": "WT, E46K, A30P, A53T, A30P/A53T αS",
        "Description": "Wild-type αS (WT) and mutant αS peptides (E46K, A30P, A53T, A30P/A53T) were purchased from Recombinant Peptide Technologies."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.136G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "accelerated secondary structure change",
          "Result Description": "E46K αS displayed substantially accelerated kinetic of secondary structure change."
        },
        {
          "Variant": "NM_000345.4:c.88G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "decelerated secondary structure change",
          "Result Description": "A30P αS displayed decelerated kinetic of secondary structure change."
        },
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "accelerated secondary structure change",
          "Result Description": "A53T αS displayed slightly accelerated kinetic of secondary structure change."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "The spectra presented at each time are representative of those obtained during each of 3 independent experiments."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Ten scans were acquired and averaged for each sample."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type αS was used as a control."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}